Means for inhibiting the expression of protein kinase 3

Details for Australian Patent Application No. 2007276388 (hide)

Owner Silence Therapeutics AG

Inventors Kaufmann, Jorg; Santel, Ansgar; Keil, Oliver

Agent Pizzeys

Pub. Number AU-A-2007276388

PCT Pub. Number WO2008/009477

Priority 06015262.6 21.07.06 EP

Filing date 20 July 2007

Wipo publication date 24 January 2008

International Classifications

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2008/009477 Priority application(s): WO2008/009477

6 August 2009 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor to read from Kaufmann, Jorg To Kaufmann, Joerg

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007276395-Process for manufacturing 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy )-1-(3phenoxypropyl)-1 - azoniabicyclo[2.2.2]octane bromide

2007276387-Concentrated methotrexate solutions